Agoracom Blog

CLIENT FEATURE: Novamind $ Leaders In #Psychedelic Medicine $ $MMED $ $ $CMPS $

Posted by AGORACOM-JC at 11:44 AM on Friday, February 12th, 2021


Why Novamind?

  • Building the infrastructure required for a regulated psychedelics industry
  • Rapidly expanding a network of outpatient mental health clinics and research sites
  • Provides ketamine-assisted psychotherapy and Spravato™ (esketamine) treatments;
    • Ketamine treatment volume grew 90% from 2019 to 2020
    • During the same period, total Spravato™ treatments rose 400%
  • Positioned to facilitate MDMA and psilocybin therapy post-FDA approval
  • Specializing in psychedelic-assisted treatment protocols
  • Building centers of excellence for future approved psychedelic treatments
  • Approximately CAN$1,900,000 in 2019 revenue
  • Strong insider ownership (32.3%) 

Yaron Conforti, CEO of Novamind Featured On Cheddar News

Novamind is focused on 3 pillars:

FULL DISCLOSURE: Novamind is an advertising client of AGORA Internet Relations Corp.

Hub On AGORACOM / Corporate Profile

Tags: , , , , , , ,

Comments are closed.